Market Snapshot

S&P Futures
4,185.50
Dow Futures
33,071.00
NASDAQ Futures
14,103.00

0.57$-0.03 -5.68%
Market open    15:33:30 pm   
From: To:

Stock Snapshot

0.60
Prev. Close
0.60
Open
50.77M
Market Cap
1.88M
Number of Shares
0.5659
Day Low
0.6084
Day High
0.57
-
P/E Ratio
21.75M
Free Float in %
-7.58
EPS 2021
-0.82
Book Value per Share
0.31
Cash Flow per Share
Teligent, Inc. (TLGT)
Teligent, Inc. (TLGT) stock rallied over -5.68% intraday to trade at $0.57 per share on NASDAQ. The stock opened with a fall of 0.00% at $0.60 and touched an intraday high of $0.6084, rising 1.40% against the last close of $0.60. The stock went to a low of $0.5659 during the session.

Historical Prices

DateOpenCloseAdj. CloseDaily HighDaily LowVolume
2021-06-18$0.60$0.57$0.57$0.61$0.572,063,604
2021-06-17$0.60$0.60$0.60$0.63$0.601,327,500
2021-06-16$0.61$0.60$0.60$0.62$0.591,692,900
2021-06-15$0.65$0.60$0.60$0.66$0.593,390,700
2021-06-14$0.62$0.65$0.65$0.66$0.614,007,300
2021-06-11$0.59$0.60$0.60$0.61$0.582,122,400
2021-06-10$0.60$0.58$0.58$0.60$0.561,806,700
2021-06-09$0.60$0.58$0.58$0.61$0.581,350,300
2021-06-08$0.60$0.58$0.58$0.61$0.571,662,100
2021-06-07$0.60$0.60$0.60$0.62$0.592,087,100
2021-06-04$0.60$0.61$0.61$0.62$0.592,510,000
Teligent, Inc.
105 Lincoln Avenue
Buena, NJ 08310
United States

http://www.teligent.com
856 697 1441
Employees
252
Sector
Healthcare
Sales or Revenue
Industry
Drug Manufacturers - Specialty & Generic
5Y Sales Change
0.50
Fiscal Year Ends
2019-12-30
Mr. Timothy B. Sawyer
Pres, CEO & Director
Mr. Steven Pinsky
Acting Chief Financial Officer
Mr. Antonio Di Nicola
GM & VP of Operations
Teligent, Inc.
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.